Population Pharmacodynamic/Pharmacokinetic Modeling of Eculizumab and Free Complement Component Protein C5 in Pediatric and Adult Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

Author(s): C. D. Lathia, N. Kassir, M. S. Mouksassi, B. Jayaraman, J. F. Marier, C. L. Bedrosian
Year:

Learn More
LinkedIn